Results 281 to 290 of about 334,749 (357)

Cancer Vaccines: An Old Idea Comes of Age [PDF]

, 2003
Leisha A. Emens, Elizabeth M. Jaffee
openalex   +1 more source

Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine. [PDF]

Cancer Cell Int
Cen L, Zhang Z, Sun Y, Wu N, Shao J, Qian Z, Tian M, Ke Y, Liu B.   +8 more
europepmc   +1 more source

Premalignant Lesions as Targets for Cancer Vaccines [PDF]

, 2003
Olivera J. Finn
openalex   +1 more source

Enhancing antitumor immunity through the combination of cholesterolized TLR7 agonist liposomes and radiotherapy: a role for IL‐1β and the inflammasome pathway

Cancer Communications, EarlyView.
Abstract Background Radiotherapy (RT) is a key treatment modality in cancer therapy, utilizing high‐energy radiation to directly kill tumor cells. Recent research has increasingly highlighted RT's potential to indirectly enhance antitumor immunity. However, this immune activation alone often fails to generate sustained systemic antitumor responses.
Xuejiao Han, Yuan Cheng, Dandan Wan, Aqu Alu, Ziqi Zhang, Zhenfei Bi, Manni Wang, Yan Tang, Weiqi Hong, Siyuan Chen, Li Chen, Yuquan Wei   +11 more
wiley   +1 more source

Role of Biofunctionalized Nanoparticles in Digestive Cancer Vaccine Development. [PDF]

Pharmaceutics
Zdrehus R, Delcea C, Mocan L.
europepmc   +1 more source

Cancer Vaccine Therapy as Tumor Dormancy Therapy against Advamced Digestive Tract Cancer.

, 2001
Yuji Ueda, Tsuyoshi Itoh, Kaori Okugawa, Hitoshi Fujiwara, Nobuaki Fuji, Tetsunori Yoshimura, Tetsuro Yamashita, Hiroshi Fujiki, Sachio Harada, Hisakazu Yamagishi   +9 more
openalex   +2 more sources

Combating cancer immunotherapy resistance: a nano‐medicine perspective

Cancer Communications, EarlyView.
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong, Xintong Xie, Juan Wu, Xiangyu Wang, Wenxiang Zhang, Shuowen Wang, Daria Valerievna Abbasova, Yi Fang, Hongnan Jiang, Jidong Gao, Jing Wang   +10 more
wiley   +1 more source

Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity. [PDF]

Sci Adv
Fan T, Xu C, Wu J, Cai Y, Cao W, Shen H, Zhang M, Zhu H, Yang J, Zhu Z, Ma X, Ren J, Huang L, Li Q, Tang Y, Yu B, Chen C, Xu M, Wang Q, Xu Z, Chen F, Liang S, Zhong Z, Jamroze A, Tang DG, Li H, Dong C.   +26 more
europepmc   +1 more source

Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions. [PDF]

Antibodies (Basel)
McKeague ML, Lohmueller J, Dracz MT, Saadallah N, Ricci ED, Beckwith DM, Ayyalasomayajula R, Cudic M, Finn OJ.   +8 more
europepmc   +1 more source

Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study. [PDF]

Cancer Immunol Immunother
Inderberg EM, Singh N, Miller R, Arbe-Barnes S, Eriksen HK, Lversen B, Juul HV, Eriksen JA, Handeland KR.   +8 more
europepmc   +1 more source